Vasopressors in obstetrics.
D000804:Angiotensin II / Q000494:pharmacology; D004357:Drug Synergism; D004809:Ephedrine / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D006801:Humans; D007022:Hypotension / Q000188:drug therapy; D007545:Isoproterenol / Q000494:pharmacology; D008431:Maternal-Fetal Exchange; D008616:Mephentermine / Q000494:pharmacology; D008680:Metaraminol / Q000494:pharmacology; D008729:Methoxamine / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010120:Oxytocics / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D006473:Postpartum Hemorrhage / Q000188:drug therapy; D011247:Pregnancy; D012039:Regional Blood Flow / Q000187:drug effects; D013997:Time Factors; D014599:Uterus / Q000098:blood supply; D014662:Vasoconstrictor Agents / Q000494:pharmacology* / Q000627:therapeutic use
D010120:Oxytocics; D014662:Vasoconstrictor Agents; D000804:Angiotensin II; D010656:Phenylephrine; D008680:Metaraminol; D004809:Ephedrine; D008729:Methoxamine; D007545:Isoproterenol; D008616:Mephentermine; D009638:Norepinephrine; D004837:Epinephrine